SCHEMBL3868481

SCHEMBL3868481

FC(F)(F)C(F)(F)C(F)(F)C1CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5945109 0.92
SCHEMBL12978019 0.89 LMNA (0.33)
SCHEMBL12977807 0.89 LMNA (0.33)
SCHEMBL1471354 0.89 LMNA (0.33)
SCHEMBL1471228 0.89 LMNA (0.33)
SCHEMBL12977792 0.89 LMNA (0.33)
SCHEMBL9770130 0.89 LMNA (0.33)
SCHEMBL5945084 0.89 LMNA (0.33)
SCHEMBL3475186 0.89 LMNA (0.33)
SCHEMBL11387395 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3861039-B1 HYDROGEL COMPOSITIONS OPHTALMIC CIE (FR) 2023-11-01 EP disclosed
US-11679291-B2 Compositions and uses of Z-1-chloro-2,3,3,3-tetrafluoroprop-1-ene THE CHEMOURS COMPANY FC, LLC (US) 2023-06-20 US disclosed
US-20210369911-A1 HYDROGEL COMPOSITIONS UNIVERSITÉ DE HAUTE-ALSACE (FR) 2021-12-02 US disclosed
US-20210332174-A1 HYDROGEL COMPOSITIONS OPHTALMIC COMPAGNIE (FR) 2021-10-28 US disclosed
EP-3861039-A1 HYDROGEL COMPOSITIONS Ophtalmic Compagnie (FR) 2021-08-11 EP disclosed
EP-3861042-A1 HYDROGEL COMPOSITIONS Ophtalmic Compagnie (FR) 2021-08-11 EP disclosed
US-20200230454-A1 COMPOSITIONS AND USES OF Z-1-CHLORO-2,3,3,3-TETRAFLUOROPROP-1-ENE THE CHEMOURS COMPANY FC, LLC (US) 2020-07-23 US disclosed
EP-3668937-A1 COMPOSITIONS AND USES OF Z-1-CHLORO-2,3,3,3-TETRAFLUOROPROP-1-ENE The Chemours Company FC, LLC (US) 2020-06-24 EP disclosed
WO-2020070423-A1 HYDROGEL COMPOSITIONS OPHTALMIC COMPAGNIE (FR) 2020-04-09 WO disclosed
WO-2020070422-A1 HYDROGEL COMPOSITIONS OPHTALMIC COMPAGNIE (FR) 2020-04-09 WO disclosed
WO-2012158280-A1 POLYMERIC FOAMS INCLUDING FLUORINATED OXIRANES, METHODS OF PREPARATION, AND USE OF SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-11-22 WO disclosed
WO-2012134803-A2 FLUORINATED OXIRANES AS ORGANIC RANKINE CYCLE WORKING FLUIDS AND METHODS OF USING SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-10-04 WO disclosed
WO-2012134860-A1 FLUORINATED OXIRANES AS HEAT TRANSFER FLUIDS 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-10-04 WO disclosed
WO-2012118602-A1 LUBRICANT COMPOSITIONS CONTAINING FLUOROOXIRANES 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-09-07 WO disclosed
WO-2010028362-A1 POLYCARBONATE POLYOL COMPOSITIONS AND METHODS NOVOMER, INC. (US) 2010-03-11 WO disclosed
WO-2009047112-A1 A LITHOGRAPHIC PRINTING PLATE PRECURSOR AGFA GRAPHICS NV (BE) 2009-04-16 WO disclosed
EP-2047988-A1 A lithographic printing plate precursor Agfa Graphics N.V. (BE) 2009-04-15 EP disclosed
US-7220486-B2 Photoresist compositions SHIPLEY COMPANY, L.L.C. (US) 2007-05-22 US disclosed
US-20030219603-A1 Short wavelength imaging, including sub-300 nm and sub-200 nm such as 193 nm and 157 nm. Photoresists of the invention contain a resin with photoacid-labile groups, one or more photoacid generator compounds, and an adhesion-promoting SHIPLEY COMPANY, L.L.C. (US) 2003-11-27 US disclosed
EP-1341041-A2 Photoresist compositions Shipley Co. L.L.C. (US) 2003-09-03 EP disclosed